Related references
Note: Only part of the references are listed.Design and synthesis of new adamantyl derivatives as promising antiproliferative agents
Afnan Shahin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Targeting ecto-5′-nucleotidase: A comprehensive review into small molecule inhibitors and expression modulators
Gustavo Machado das Neves et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Recent progress in biologically active indole hybrids: a mini review
Esraa Mahmoud et al.
PHARMACOLOGICAL REPORTS (2022)
Synthesis and Biological Evaluation of Arylamide Sulphonate Derivatives as Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 and-3 Inhibitors
Saif Ullah et al.
ACS OMEGA (2022)
Synthesis, biological evaluation, and docking studies of novel pyrrolo 2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents
Saif Ullah et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
Wenxin Zeng et al.
CANCER CELL INTERNATIONAL (2020)
Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase
Saif Ullah et al.
BIOORGANIC CHEMISTRY (2020)
Discovery of AB680: A Potent and Selective Inhibitor of CD73
Kenneth Lawson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39
Jenna L. Jeffrey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
Laura Schaekel et al.
FRONTIERS IN PHARMACOLOGY (2020)
Synthesis of biphenyl oxazole derivatives via Suzuki coupling and biological evaluations as nucleotide pyrophosphatase/phosphodiesterase-1 and-3 inhibitors
Haseen Ahmad et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Targeting the CD73-adenosine axis in immuno-oncology
David Allard et al.
IMMUNOLOGY LETTERS (2019)
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
Ivan Perrot et al.
CELL REPORTS (2019)
Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase
Mohammed I. El-Gamal et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
J. -C. Soria et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Panobinostat andMultipleMyeloma in 2018
Andrew J. Yee et al.
ONCOLOGIST (2018)
Unveiling the Role of Ecto-5′-Nucleotidase/CD73 in Astrocyte Migration by Using Pharmacological Tools
Marija Adzic et al.
FRONTIERS IN PHARMACOLOGY (2018)
Pyrrole: An insight into recent pharmacological advances with structure activity relationship
Shujauddin Ahmad et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer
Solange Peters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Targeting immunosuppressive adenosine in cancer
D. Vijayan et al.
NATURE REVIEWS CANCER (2017)
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies
Luca Antonio et al.
DRUG DISCOVERY TODAY (2017)
Auspicious role of the steroidal heterocyclic derivatives as a platform for anti-cancer drugs
Mohamed A. Tantawy et al.
BIOORGANIC CHEMISTRY (2017)
Inhibitors for the bacterial ectonucleotidase Lp1NTPDase from Legionella pneumophila
Amelie Fiene et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Pyrrole: An emerging scaffold for construction of valuable therapeutic agents
Somnath S. Gholap
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Comprehensive evaluation of ten docking programs on a diverse set of protein-ligand complexes: the prediction accuracy of sampling power and scoring power
Zhe Wang et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2016)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Heterocyclic Scaffolds: Centrality in Anticancer Drug Development
Imran Ali et al.
CURRENT DRUG TARGETS (2015)
Insights into Ecto-5′-Nucleotidase as a New Target for Cancer Therapy: A Medicinal Chemistry Study
Patricia Frasson Corbelini et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Nintedanib: From Discovery to the Clinic
Gerald J. Roth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Influence of the diversified structural variations at the imine functionality of 4-bromophenylacetic acid derived hydrazones on alkaline phosphatase inhibition: synthesis and molecular modelling studies
Imtiaz Khan et al.
RSC ADVANCES (2015)
A novel role of alkaline phosphatase in the ERK1/2 dephosphorylation in renal cell carcinoma cell lines: A new plausible therapeutic target
Ujjawal Sharma et al.
BIOCHIMIE (2014)
Synthesis and identification of α-cyano bis(indolyl)chalcones as novel anticancer agents
Dalip Kumar et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Therapeutic Potentials of Ecto-Nucleoside Triphosphate Diphosphohydrolase, Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase, Ecto-5′-Nucleotidase, and Alkaline Phosphatase Inhibitors
Mariya al-Rashida et al.
MEDICINAL RESEARCH REVIEWS (2014)
Catalytic Signature of a Heat-Stable, Chimeric Human Alkaline Phosphatase with Therapeutic Potential
Tina Kiffer-Moreira et al.
PLOS ONE (2014)
Cancer-Related Inflammation
Juliana Candido et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
CD39 and CD73 in immunity and inflammation
Luca Antonioli et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma
Zhen-kui Qiao et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Fast force field-based optimization of protein-ligand complexes with graphics processor
Lennart Heinzerling et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2012)
The expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (E-NPP1) is correlated with astrocytic tumor grade
Indra Aerts et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2011)
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Sergey Ryzhov et al.
JOURNAL OF IMMUNOLOGY (2011)
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors-An Update
Bertil B. Fredholm et al.
PHARMACOLOGICAL REVIEWS (2011)
Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation
Joanna Lecka et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Development of Potent and Selective Inhibitors of ecto-5′-Nucleotidase Based on an Anthraquinone Scaffold
Younis Baqi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Recombinant ecto-5′-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation
Nathaniel A. Sowa et al.
MOLECULAR PAIN (2010)
Differential expression of nucleotide pyrophosphatase/phosphodiesterases by Walker 256 mammary cancer cells in solid tumors and malignant ascites
Andreia Buffon et al.
LIFE SCIENCES (2010)
Extracellular adenosine triphosphate and adenosine in cancer
J. Stagg et al.
ONCOGENE (2010)
Trichomonas vaginalis nucleoside triphosphate diphosphohydrolase and ecto-5′-nucleotidase activities are inhibited by lycorine and candimine
Raquel B. Giordani et al.
PARASITOLOGY INTERNATIONAL (2010)
Nucleoside-5′-monophosphates as Prodrugs of Adenosine A2A Receptor Agonists Activated by ecto-5′-Nucleotidase
Ali El-Tayeb et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A highly sensitive CE-UV method with dynamic coating of silica-fused capillaries for monitoring of nucleotide pyrophosphatase/phosphodiesterase reactions
Jamshed Iqbal et al.
ELECTROPHORESIS (2008)
The role of membrane glycoprotein plasma cell antigen 1 ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities
Ira D. Goldfine et al.
ENDOCRINE REVIEWS (2008)
The role of ecto-5′-nucleotidase/CD73 in glioma cell line proliferation
Luci Bavaresco et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases
S. A. Levesque et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
NTPDase and 5 '-nucleotidase activities in physiological and disease conditions: New perspectives for human health
Maria Rosa C. Schetinger et al.
BIOFACTORS (2007)
New biscoumarin derivatives-cytotoxicity and enzyme inhibitory activities
Muhammad Iqbal Choudhary et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Sunitinib in patients with metastatic renal cell carcinoma
Robert J. Motzer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Ecto-5′-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury
Jonathan B. Volmer et al.
JOURNAL OF IMMUNOLOGY (2006)
Expression of ecto-5 '-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma
Rafal Sadej et al.
MELANOMA RESEARCH (2006)
Role of estrogen receptor in the regulation of ecto-5′-nucleotidase and adenosine in breast cancer
J Spychala et al.
CLINICAL CANCER RESEARCH (2004)
Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase
A Kozlenkov et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis
HJ Buhring et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2004)
Ecto 5′-nucleotidase and nonspecific alkaline phosphatase -: Two amp-hydrolyzing ectoenzymes with distinct roles in human airways
M Picher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion
B Grobben et al.
CELL AND TISSUE RESEARCH (2002)
Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase
A Tokumura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Purine signaling and potential new therapeutic approach: Possible outcomes of NTPDase inhibition
FP Gendron et al.
CURRENT DRUG TARGETS (2002)
Tumor-promoting functions of adenosine
J Spychala
PHARMACOLOGY & THERAPEUTICS (2000)
Share Paper
